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Background: Recently, the diagnosis of sepsis was redefined and of today there is no gold 
standard for diagnosing the syndrome. The increasing use of different screening tools for 
identifying sepsis in the Emergency Department (ED) calls for validation.  
 
Objective: To evaluate the clinical usefulness of qSOFA, SIRS, TILT and NEWS as early 
warning scores for sepsis and in prediction of mortality in patients with suspected infection 
admitted to the ED. To assess if a modification by including risk factors to the different 
scoring tools could improve early recognition of sepsis. 
 
Methods: The study was a retrospective study performed in the ED at a single center hospital 
in Norway in the period October 1. 2017 – January 14. 2018. The study sample consisted of 
patients (n=391) who were either received by The Emergency Medical Team (EMT) or were 
later admitted to the Department of Infection with either a yellow, orange or red triage 
according to the Rapid Emergency Triage and Treatment System (RETTS). Patients were 
selected using data from DIPS (the hospitals electronic health record). We measured 
sensitivity, specificity and area under the receiver characteristic curve (AUC) for detection of 
sepsis and mortality as end point.  
 
Results: Of 391 patients screened, 270 patients were included and 139 had sepsis. 
NEWS  4 was of most clinical usefulness in detection of sepsis with a sensitivity of 0.78 
(95% CI: 0.71-0.84) and a specificity of 0.59 (95% CI: 0.50-0.67). qSOFA  2 had lowest 
sensitivity with 0.48 (95% CI: 0.40-0.56), but highest specificity with 0.95 (95% CI: 0.90-
0.98). Overall mortality was 27 %. NEWS identified most patients who experienced death 
within 7-days, 30-days and 1-year although the ROC curve of qSOFA was higher than of 
NEWS in predicting mortality. All modified screening tools demonstrated an increased ability 
to identify sepsis.  
 
Conclusions: All scoring systems were able to recognize patients with sepsis. NEWS was 
found to be of more clinical usefulness compared to qSOFA, SIRS and TILT in early 
identification of sepsis. NEWS is at least equivalent or better than the other screening tools 
across most measures in predicting mortality. Our finding suggests that the implementation of 








ARDS  Adult Respiratory Distress Syndrome 
AUC  Area under the curve 
CI  Confidence Interval 
CO Cardiac Output 
CVPU (new) Confusion, Voice, Pain, Unresponsive 
DIC Disseminated Intravascular Coagulation 
ED Emergency Department 
EMT Emergency Medical Team 
EPR Electronic Patient Records 
ESS Emergency Signs and Symptoms  
GCS Glasgow Coma Scale 
HIV Human Immunodeficiency Virus 
ICD-10  International Classification of Diseases 10th revision 
ICU  Intensive Care Unit 
MAP Mean Arterial Pressure 
MeSH Medical Subject Headings 
MEWS Modified Early Warning Score 
NEWS National Early Warning Score 
NPR  Norwegian Patient Registry 
OR  Odds Ratio 
qSOFA Prehospital early sepsis detection (score), Quick SOFA 
RETTS  Rapid Emergency Treatment and Triage System 
ROC  Receiver Operating Characteristic 
SIRS Systemic Inflammatory Response Syndrome 
SOFA  Sequential (sepsis induced) Organ Failure Assessment 
TILT “Tidlig Identifisering av Livstruende Tilstander” 
UNN  University Hospital of Northern Norway 






DIPS A system for electronic patient record (EPR). 
 
Infection Microbial phenomenon characterized by an inflammatory response to the 
presence of microorganisms or the invasion of normally sterile host tissue 
by those organisms. 
 
NPR NPR is a national database run by the Norwegian Directorate of Health, 
containing information about all hospital admissions in Norway (patient 
data, dates of hospitalization, type of hospital and Department, vital status 
at discharge and discharge codes). 
Organ dysfunction According to Task Force of the European Society of Intensive Care 
Medicine (ESICM) and the Society of Critical Care Medicine (SCCM) 
organ dysfunction should be defined according to the scoring system 
Sequential Organ Failure Assessment (SOFA) score (Table 5). An acute 
change in total SOFA score ≥ 2 points is to be understood as organ 
dysfunction. 
Scoring systems Scoring systems are tools that may heighten the clinical suspicion for a 
condition, for example sepsis, and encourage physicians to perform time-
critical interventions. 
 
Sepsis-1 Sepsis-1 was presented in 1991 and defined sepsis as the systemic 
inflammatory response syndrome (SIRS) to a confirmed infectious 
process. Criteria for SIRS are presence of 2 out of 4 of: heart rate >90/min, 
respiratory rate >20/min, temperature >38 or <36oC or leukocyte count 
>12 000/cu mm or <4000/cu mm or >10% immature (band) forms. Severe 
sepsis was defined as sepsis + organ dysfunction, but criteria for organ 





Sepsis-2 Sepsis-2 is often used for the definition according to the second sepsis 
consensus conference in 2001. The basic definition of sepsis was retained, 
and the list of sepsis criteria was expanded.  
 
Sepsis-3 Sepsis-3 was launched in 2016. The new definition of sepsis now includes 
organ dysfunction. Sepsis is now defined as life threatening organ 
dysfunction caused by a dysregulated immune response to an infection. 
Criteria for sepsis-3 are an increase of 2 points or more from baseline in 
the SOFA-score (Table 5). The term severe sepsis is no longer in use. 
 
Septic shock Sepsis with hypotension despite adequate fluid resuscitation along with 
the presence of perfusion abnormalities that may include:  
 lactic acidosis 
 oliguria 
 an acute alteration in mental status.  
Patients who are receiving inotropic or vasopressor agents may not be 
hypotensive at the time that perfusion abnormalities are measured. 
 
The local definition 
of organ dysfunction, 
UNN 
The UNN´s definition of sepsis is the same as in Sepsis-3.  
Organ dysfunction, however, was defined as listed on page 11. 







The definition of sepsis and the characterization of its different stages have changed three 
times in the past 28 years, most recently in March 2016 by the Sepsis-3 Task Force (2). They 
recognized the need to reexamine the current definitions of sepsis as a systemic inflammatory 
response syndrome (SIRS) due to infection (3). Sepsis is today defined as a life-threatening 
organ dysfunction caused by a dysregulated host response to infection (4).  
 
Sepsis is a complex syndrome and is not completely understood (5). As of today, there is no 
gold standard for diagnosing sepsis. This has led to extensive research into diagnosis and 
treatment (1, 6). Sepsis remains a significant global health challenge and is one of the most 
common reasons for hospitalization and admissions to the intensive care unit (ICU) (7).  
 
Clinically, sepsis is difficult to diagnose with symptoms often being non-specific. It is 
especially challenging within certain groups of people, like elderly, who are at greater risk of 
developing sepsis (8, 9). Early detection and management, including starting antibiotics 
within one hour after suspicion of sepsis, can improve and reduce morbidity and mortality 
(10).  
 
Most patients admitted to a hospital with sepsis are initially assessed in the Emergency 
Department (ED). In the ED identification of sepsis is based on clinical judgment, experience 
and different clinical scoring systems (11, 12). A good scoring system may be useful in a 
clinical setting, helping doctors to identify patients at risk of sepsis and to give appropriate 
treatment as promptly as possible.  
 
In 2016-2018 the Norwegian Board of Health Supervision performed a nationwide 
surveillance of the EDs in Norway. The aim was to investigate whether identification, 
diagnosis and treatment of patients with sepsis and suspected sepsis in the ED were adequate 
(13). Results from the first evaluation at UNN revealed that the majority of patients with 
sepsis received delayed examination by a doctor. Furthermore, the report confirmed that many 
patients with sepsis were not identified and the time from admission to establishing treatment 







Infections can affect all parts of the body, be localized or systemic. The severity ranges from 
mild infection to sepsis and septic shock. Multiple definitions and terminologies have been 
used to define both sepsis and septic shock, leading to inconsistency in diagnosing and 
reporting. The validity and clinical utility of the sepsis definitions have been questioned over 
the years. This led to redefinitions in 1991, 2001 and 2016 (2).  
 
In 1991, an American consensus meeting (Sepsis-1) defined sepsis as the Systemic 
Inflammatory Response Syndrome (SIRS), with a score of two or higher in a response to a 
confirmed infection process (Table 1). The syndrome was divided into three subgroups; 
sepsis, severe sepsis and septic shock (12). However, the definition has been criticized for 
being overly sensitive and reporting many false negative cases (14, 15). This led to a second 
international consensus conference in 2001 (Sepsis-2). The basic definition of sepsis was 
retained, but the list of sepsis criteria was expanded (11). In 2016, based on new research 
findings, another new definition of sepsis was suggested by the Third International Sepsis 
Definitions Task force, designated Sepsis-3 (2). 
 
In Sepsis-3, sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated 
host response to infection. Organ dysfunction can be represented by an increase in the 
Sequential, (sepsis-related), Organ Failure Assessment (SOFA) score of 2 points or more, in 
consequence of an infection (2) (Table 5). SOFA is commonly used inside the intensive care 
unit (ICU) and requires laboratory findings. In order to identify patients with sepsis outside 
the ICU, the Task Force introduced The Quick Sequential Organ Failure Assessment 
(qSOFA) score as a new screening tool (Table 2). A positive qSOFA score should stress the 
clinicians to further investigate for organ dysfunction and initiate appropriate measures (2, 
16).  
 
The Task Force further defined septic shock as a subset of sepsis, identified with persisting 
hypotension that requires vasopressors to maintain mean arterial pressure  65 mmHg and 
serum lactate level > 2mmol/l despite adequate volume resuscitation (2). They eliminated the 





Sepsis is a medical emergency, requiring early and effective treatment. A key strategy to 
improve management is to recognize and identify patients with sepsis at an early stage. This 
is important to prevent an adverse outcome (17). Different scoring systems such as qSOFA 
and SIRS are already commonly implemented in clinical practice outside the ICU. However, 
systems like “Tidlig identifisering av livstruende tilstander” (TILT) and the National Early 
Warning Score (NEWS) are track and trigger monitoring systems in use for detection of acute 
illness. These scoring tools are in use in several Norwegian hospitals. If these scoring tools 
can be shown to be of equivalent or higher prognostic accuracy in detecting sepsis, the 
rationale for using either qSOFA or SIRS may be called into question (18). 
 
1.2.2 Triage 
Triage is the first point of contact when a person arrives to the ED. At this point, the urgency 
of the patients´ conditions is decided and consequently how fast the patients will need 
medical evaluation and treatment. Emergency departments around the world use different 
triage systems to assess the severity of admitted patients´ conditions and to assign treatment 
priorities. Multiple patients may present with conditions that are time sensitive, like for 
example sepsis (19-21). A good triage screening and assessment tool may identify these 
patients as early as first triage.  
 
1.2.3 Rapid Emergency Triage and Treatment System (RETTS) 
RETTS is the most commonly used triage system in Norway and is currently in use at UNN. 
RETTS uses a combination of the patient´s presenting symptoms and signs in addition to vital 
values to categorize patients into different priority groups. Symptoms and signs are matched 
to one of the Emergency Signs and Symptoms (ESS) algorithms in accordance with RETTS-
A and vital values are measured. The patient´s final triage priority is based on the most urgent 
findings. There are four priority categories: Red (immediate evaluation by a doctor), orange 
(can wait 10 minutes before evaluation), yellow (can wait 60 minutes before evaluation), 
green (can wait 120 minutes before evaluation), blue (can wait 240 minutes before evaluation) 
(20, 22).  
 
1.2.4 Scoring systems 
Early identification of sepsis requires attention to symptoms and signs (8). To the clinician, it 
is of prime interest to identify patients with both infection and suspicion of sepsis at an early 




critical interventions, different scorings systems can be used. These have been introduced to 
help identify patients with sepsis and to determine the severity. Each scoring system uses 
different combination of parameters, and there is no consensus which scoring system is best 
in clinical practice (23). Screening tools are not adequate to make a diagnosis but may serve 
to identify patients at risk and to stratify the risk of an adverse outcome (24). 
 
1.2.4.1 SIRS 
Systemic inflammatory response syndrome (SIRS) can be used to identify sepsis. A positive 
SIRS requires a presence of an infection and two or more of the following four conditions: 
temperature >38°C or <36°C, heart rate >90/min, respiratory rate > 20 breaths/min or  
PaCO2 < 4.3 kPa and leukocyte count >12 000/cu mm or <4000/cu mm or >10% immature 
(band) forms (12) (Table 1). 
 
1.2.4.2 qSOFA 
qSOFA is a new scoring tool that does not require laboratory tests and can be assessed 
quickly and repeatedly. It was developed to rapidly assess the patient clinically for risk of 
deterioration due to sepsis outside of the ICU (2). qSOFA requires the presence of an 
infection and two of the following three criteria: respiratory rate ≥22/min, systolic blood 
pressure ≤100 mmHg and any alteration in mental status (4) (Table 2).  
 
1.2.4.3 TILT 
TILT score is developed by a regional hospital in Agder, Norway. It is a paper-based 
evaluation tool for early identification of life-threatening conditions. It is based on the 
modified early warning score (MEWS) and includes the vital parameters; pulse, temperature, 
respiratory rate, blood pressure and mental status. Each parameter is assigned a value from  
0-3 according to level of severity. With a score ≥ 4 the patient should be seen by a doctor (25)  
(Table 3).  
 
1.2.4.4 NEWS 
NEWS is based on the earlier VIEWS (VitalPAC Early Warning Score) and is implemented 
in hospitals across Europe. It has been developed to make a standardized system for early 
detection of patients with acute illness. NEWS was first produced in 2012. An updated 





NEWS contains of six physiological parameters (Table 4). Each of which is assigned a value 
between 0 and 3, along with an additional parameter for supplemental oxygen, which scores 0 
or 2. Updated NEWS has a dedicated section (SpO2 scale 2) for use in patients with 
hypercapnic respiratory failure. The parameters are summed to calculate the NEWS which 
may range between 0 and 20. Several studies have used different cutoff points for screening 
potential infectious patients for sepsis (18, 27, 28). 
 
1.3 Epidemiology  
In 2013, sepsis was ranked as the most expensive medical condition in a national study of 
inpatient hospital costs in the U.S.(29). An accurate estimate of the incidence and mortality of 
sepsis is difficult given the difficulty of diagnosing the syndrome. Multiple definitions and 
terminologies of sepsis have been used and this has led to major variations in reported 
incidence and mortality rates (2). The hospital mortality of sepsis has ranged from 25% to 
80% over the last few decades (30). Studies have shown that the incidence of sepsis increases 
with age and men have a higher incidence than women in all age groups (31).  
 
A Norwegian study from 1999 reported an overall sepsis incidence of 149 per 100 000 
inhabitants per year, with a mean mortality of 13.5% (32). In a recent Norwegian national 
study from 2017, the overall incidence of hospitalized sepsis was 140 per 100 000 individuals 
per year. The incidence of sepsis in USA is estimated to be 300 cases per 100 000 population 
and is killing one in four (33-36). This indicates that sepsis is not uncommon.  
 
1.4 Infection and pathophysiology in sepsis 
An infection can affect all parts of the body. Both the microbe, the host properties and the 
time to diagnosis and treatment are crucial for the outcome. The pathophysiology of sepsis is 
still debated and not yet completely understood. Over the years it has become apparent that 
the key event in sepsis is a systemic inflammatory response to infectious agents (37). 
 
If the microorganisms overcome the initial immune response, they spread to distant tissues 
and organs via the blood stream. The body triggers production of inflammatory mediators that 
are characterized by an inflammation and immune suppression (38, 39). If the immune system 
is healthy and the microorganisms involved are below a tolerance limit, the infection will be 




The unbalanced immune response leads to a systemic release of pro-inflammatory cytokines, 
chemokines and vasoactive amines. The high amount of pathogens in the bloodstream during 
sepsis produce a severe acute reaction, which in turn can lead to microembolisms, bleeding 
and organ dysfunction (40). 
 
Early in the course of sepsis, the body reacts by increasing the cardiac output (CO) to 
maintain blood pressure and organ perfusion as a response to reduced peripheral vascular 
resistance. As sepsis progresses, CO may frequently be reduced (41). Vasoactive mediators 
give vasodilation and together with increased endothelial permeability, the patient is in risk of 
edema and hypotension (42).  
 
1.5 Clinical signs and symptoms  
Patients with sepsis may present with different clinical symptoms depending on 
microorganisms, organ system involved and the patients´ predisposition for sepsis. The signs 
and symptoms of sepsis are often non-specific. Sepsis may initially look like flu, 
gastroenteritis or a chest infection with nausea, vomiting, diarrhea and ileus (43).  
 
Early symptoms and signs may include fever or hypothermia. The absence of fever is more 
likely in the elderly, debilitated patients, patients with chronic alcohol abuse and in patients 
with uremia or hypothermia. Normal temperature may occur in immunosuppressed patients 
with sepsis (43-45). Furthermore, increased heart rate, hyperventilation and sometimes 
confusion or disorientation are often seen at an early stage (45).  
 
As sepsis progresses it may result in anaerobic metabolism with high values of blood lactate 
leading to metabolic acidosis. Furthermore, vasoactive mediators and changes in permeability 
may lead to hypotension and result in a low urinary output. Sepsis is also associated with a 
number of peripheral manifestations involving the skin. The skin may be cold, clammy, pale, 
cyanotic or mottled and can develop rashes (43, 45). 
 
At present, there is no single laboratory test that can accurately identify sepsis. However, 
drastic and acute change in biomarkers, should alert every doctor to include sepsis as a 
possible or contributing cause of these changes. Several biomarkers have been proposed and 
used to diagnose the syndrome. These laboratory findings include leukocytosis or leucopenia, 




of C-reactive protein, ferritin, fibrinogen and complement components. Liver enzymes may 
also be abnormal, with elevated serum conjugated bilirubin and alkaline phosphate (45). 
 
Sepsis has a number of serious complications. Acute respiratory distress syndrome (ARDS), 
acute renal injury (AKI) and disseminated intravascular coagulation (DIC) account for some 
of the most important organ dysfunctions (46). Complications may be fatal if left untreated or 
treated too late. If sepsis progresses to failure in multiple organs and shock, it may lead to 
death (38).  
 
1.6 Risk factors associated with sepsis  
Evidence suggests that some patients are at greater risk of developing sepsis because they are 
less able to fight infections due to changes in the immune system (47). In the presence of 
infection, risk factors should be considered and get the doctor to consider sepsis. Literature 
shows that age is an important risk factor, especially people over the age of 75 years who 
have comorbidities and reduced immune system or functional limitations (48). Elderly are 
especially vulnerable to community-acquired pneumonia and urinary tract infections which 
further predispose them for sepsis (49).  
 
Another important risk factor is immunosuppression. Immunocompromised patients are often 
more vulnerable of community acquired infections as well as opportunistic infections. In this 
group of patients the symptoms may be masked or altered which makes it even harder to 
identify sepsis (50). Therefore, sepsis should be considered in every change in their condition 
(51). A complete list over possible risk factors are shown on page 13.  
 
1.7 Sepsis, antibiotics and national guidelines  
Sepsis is a time-sensitive illness since the disease develops rapidly and is potentially life 
threatening. Fast and proper diagnosis and appropriate treatment with antibiotic is essential 
for the outcome (52). Delayed antimicrobial therapy is associated with increased mortality 
and increases the risk of septic shock (53, 54). The mortality has been shown to increase by 
7.6% for every hour of delay in starting antibiotic therapy (17, 55, 56). 
 
Empirically antimicrobial therapy for sepsis should be broad from the start and the suspected 




than one antimicrobial is frequently needed. Empirically antimicrobial therapy should cover 
both gram-positive and gram-negative bacteria and be capable of achieving therapeutic drug 
levels in the infected organ (57, 58). 
 
International and national guidelines recommend initiating broad-spectrum antibiotics within 
one hour after suspected sepsis (1, 59). The national guidelines for treating sepsis in Norway 
are outlined in the national guideline for antimicrobial therapy issued by The Norwegian 
Directorate of Health and is currently under revision (60). Sepsis with unknown origin is 
treated with benzylpenicillin combined with an aminoglycoside (61). Aminoglycosides are 
rapid bactericides and are effective against a majority of microbes that are relevant in 




The overall aim of this thesis was to evaluate the clinical usefulness of four different scoring 
tools as early warning score for sepsis in patients with suspected or confirmed infection in the 
ED.  
 
The specific objectives were: 
 To evaluate the clinical usefulness of qSOFA, SIRS, TILT and NEWS for early 
identification of sepsis.  
 To evaluate the usefulness of qSOFA, SIRS, TILT and NEWS in prediction of 7-days, 
30-days and 1-year mortality. 
 To assess if a modification of qSOFA, SIRS, TILT and NEWS by including risk 





3 Materials and Methods  
3.1 Search strategy  
Before initiating the study, we searched for relevant literature. Searches were performed 
01.04.17, 01.09.18 and 01.02.19. 
 
We used the following databases: 
 Pubmed 
 Google scholar 
 
We used the following main search options: 
I. “Sepsis” and “definition” and “organ failure” 
II. “Sepsis” and “identification”  
III. “Sepsis” and “screening tools” and “early warnings score” 
IV.  “Sepsis” and “SIRS” and “qSOFA” and “TILT” and “NEWS” and “MEWS” and 
“RETTS” 
V. “Sepsis” and “pathophysiology” 
VI. “Sepsis” and “outcome” and “treatment” 
VII.  “Sepsis” and “antibiotics” 
 
We used MeSH terms to give the search high sensitivity: 
 Etiology 
 Sign and symptoms  
 Hemodynamic 
 Immune response 
 Risk factors 
 
The findings were put in a digital library of references, EndNote X8 and X9. 
 
3.2 Study design 
We performed a retrospective study at a single center hospital. The data was obtained from 






3.3 Study sample 
The study was performed in the ED at UNN, an urban teaching hospital in Tromsø, Norway 
in the period 01.10.17-14.01.18. Patients eligible for selection were either received by The 
Emergency Medical Team (EMT) or were later admitted to the Department of Infection. 
 
3.3.1 Inclusion and exclusion criteria 
Patients were selected using the following inclusion criteria: age  18, clinically suspicion of 
or confirmed infection according to the reason of admission, those who met the criteria for 
RETTS triage scale level yellow, orange, red and patients with no triage. We excluded 
patients younger than 18 years, those who had green and blue triage, patients treated with 
antibiotics in primary care and those who were admitted to all other Departments (Figure 1).  
 
3.4 Data collection  
3.4.1 Sources of data information  
The authors reviewed the medical records of all eligible patients. We systematically searched 
through medical records (emergency-journal, admission note, discharge report) in DIPS using 
the patients´ NPR number. Data was registered into an excel spreadsheet. The spreadsheet 
was made together with our supervisor. Mortality data is reported in DIPS, with updated 
information from the Norwegian population registry.  
 
3.4.2 Procedure of data collection 
In this retrospective study, we discriminated between patients who had an infection with no 
suspicion of sepsis (sepsis = no), and those who had suspicion of sepsis (sepsis = yes). We 
defined patients with sepsis according to Sepsis-3. For identification of organ dysfunction, we 
screened to see if the patients fulfilled the consensus criteria of the local guideline at UNN 
which contains some minor modifications compared to the SOFA score, listed in Textbox 1. 
Organ dysfunction was defined as having one of the following parameters in an organ that 
was not directly affected by the infection. The parameters were retrospective registered by 





Textbox 1                       Local sepsis guideline for organ dysfunction, UNN 
Parameters  
 
Alteration of mental 
status? 
 
Signs of somnolence, confusion or impaired consciousness or 
GCS<15 
 
Acute kidney failure? Increase in s-creatinine > 26 µmol /L (last 48h) or 
increased ≥1.5x baseline or developed over the last seven days or 
signs of oliguria or anuria 
Liver failure? Bilirubin> 25 µmol/L 
Coagulopathy? 30% reduction in platelets or 
<150 109/L in platelets or 
INR > 1.5 
 
Affected / changed 
respiration? 
< 90% SpO2 without oxygen 
Affected / changed 
circulation? 
Skin: 
Cyanotic skin, lips or tongue, marbled, cold peripheral, clammy 
skin or reduced capillary filling  
 
Signs of hypotension: 
Systolic BT <100mmHg or 
decreased BT > 40mmHg from habitual BT or 
MAP <70mm Hg 
 
Acidosis? Lactate > 2 mmol/L or 
base excess ≤ -5 
 
We gathered variables from the emergency journal. In order to standardize data collection, we 
recorded clinical and physiologic data registered at the time of arrival in the ED. These values 
were used to score patients according to the four tools for sepsis, qSOFA, SIRS, TILT and 
NEWS. If these arrival data were missing from the emergency-journal, we looked into the 
admission note.  
 
The following variables were recorded: 
 Gender: male/female 
 Age  
 Reason for admission 
 Final diagnosis: ICD-10 diagnoses collected from the patients discharge note 




 Scoring tools: Vital signs, symptoms and laboratory findings were used to calculate 
and score each patient (Table 1-4) 
o qSOFA, (0-3 points), qSOFA positive = 2 or more 
o SIRS, (0-4 points), SIRS positive = 2 or more  
o TILT, (0-15 points), TILT positive = 4 or more 
o NEWS, (0-20 points), NEWS positive = 4 or more / 5 or more 
 if otherwise not stated, NEWS is further referred to have a cutoff value 
of  4  
 Mortality within 7-days, 30-days or 1-year: yes/no 
 Antibiotic treatment: type of antibiotics  
 Clinical judgement by the doctor in the ED: yes/no  
o Clinical judgement was based on the patient history with special reference to 
the vital parameters.  
o Judgement was also based on the following;  
 Treatment given (empiric antibiotic therapy and broad-spectrum 
antibiotics)  
 Use of scoring tools  
 Suspicion of sepsis commented by the doctor  
 Risk factors: No risk factor was given 0-point, one risk factor was given 1-point and 
two or more risk factors were given 2-points. Risk factors are listed in  
Textbox 2.  
 
In the present study, we defined risk factors as having one of the conditions listed in Textbox 
2. This list is currently in use at UNN and is based on a publication from The National 












Textbox 2                 Risk factors for sepsis. Local guideline, UNN 
 
 Patients <1-year or >75 years old, or very frail people 
 Patients who have impaired immune systems because of illness or drugs: 
o Chemotherapy for cancer treatment 
o Impaired immune function (such as those with HIV, diabetes or sickle cell 
disease, or people who have had a splenectomy) 
o Long term treatment with corticosteroids 
o Treatment with immunosuppressant drugs for non-malignant disorders, such 
as rheumatoid arthritis 
 Patients who have had surgery, or other invasive procedures in the past six weeks 
 Patients with any breach of skin integrity (such as cuts, burns, blisters, or skin 
infections) 
 Patients who misuse drugs intravenously  
 Patients with alcohol abuse  
 Patients with indwelling lines or catheters 
 Women who are pregnant or have given birth including cesarean section or had a 
termination of pregnancy or miscarriage in the past six weeks 
 
3.4.3 Modified screening tools 
In this study, we performed a modification of qSOFA, SIRS, TILT and NEWS by including 
“Risk factors” as an extra parameter. The modified versions are shown in Table 12. One point 
was added to each scoring system if the patient had one or more risk factors according to the 
criteria in Textbox 2. Eventually, we compared the performance of the modified tools against 
the classical in early recognition of sepsis in the ED. 
 
3.4.4 Statistical analysis 
Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 25.0. 
(Armonk, NY: IBM Corp).  
 
Data regarding our study sample is presented using descriptive analyses with frequency 
tables, median and means. Clinical usefulness was quantified by calculating the sensitivity 
and specificity for each scoring tools. Results are reported with 95% Confidence Interval (CI). 




used logistic regression to estimated odds ratio (OR). Chi-square test was used to compare the 
relationship between the different scoring tools and sepsis. 
 
Receiver operating characteristic (ROC) curve is a statistical method that measures diagnostic 
accuracy of a test. A computer-generated ROC diagram plots the true positive rate 
(sensitivity) of a test on the y-axis against the false positive rate (100-specificity) on the x-
axis, yielding the ROC area under the curve (AUC) (63, 64). In this study, the ROC curve and 
area under the ROC curve (AUC) were used to discriminate how well different scoring 
systems identified sepsis. We also used AUC values to determine the relationship between the 
different tools and mortality. AUC can range from 0.5 to 1.0. In this thesis, a value of 1.0 
indicates a perfect discriminator ability. An AUC value > 0.8 is considered good, a range 
between 0.50-0.79 is considered as moderate, and an AUC value < 0.49 is considered as poor 
(65, 66). 
 
3.5 Formal approval 
This study is based on a quality improvement perspective, without additional intervention. 
Therefore, it was sufficient with approval from the Data Protection Officer at UNN, which 
authorizes the registration of data in a local quality register, as provided in the Health Care 
Act, §26. Approval of the Local Quality Register from the Security Representative at UNN 
Tromsø is available from 10.10.2017 and is valid three years from that date, attachment 8.2. 
 
4 Results 
4.1 Study sample characteristics 
During the study period, 391 patients were selected and 270 (69%) fulfilled our inclusion 
criteria. The mean and median age of the study sample were 64 and 69 years (range, 18-99 
years), with the majority 151 (56 %) being male. Sepsis was identified in 139 (52%) of the 
270 patients who met the inclusion criteria, of whom 86 (62%) were men. Out of the 139 
patients with sepsis 94 (68%) were over 65 years and 68 (49%) of the patients were over 75 
years. Study sample characteristics are summarized in Table 6. 
 
4.2 Comparison of the different scoring tools 




Using the first vital parameter recorded at the time of arrival in the ED, qSOFA  2 identified 
67 patients whereas SIRS  2 identified 106, TILT  4 identified 81, NEWS  4 identified 
109 and NEWS  5 identified 99 patients.  
 
NEWS  4 had the highest sensitivity with 0.78 (95% CI: 0.71-0.84) and a specificity of 0.59 
(95% CI: 0.50-0.67). qSOFA had the lowest sensitivity, 0.48 (95% CI: 0.40-0.56), but the 
highest specificity with 0.95 (95% CI: 0.90-0.98).  
 
The predictive performance of the different tools is shown in Figure 2, Table 7 and Table 8. 
The Area Under the receiver operating Characteristic curves (AUC) for identification of 
sepsis was poorest for SIRS, with an AUC of 0.61 (95% CI: 0.55-0.68), while qSOFA had an 
AUC of 0.72 (95% CI: 0.66-0.78). TILT and NEWS showed the similar value with no 
significant difference.  
 
Table 9 outlines the odds ratio (OR) for sepsis. The OR was highest for positive qSOFA 
(0.19, 95% CI: 0.08-0.47), and lowest for positive SIRS (0.03, 95% CI: 0.02-0.05).  
 
The Chi-Square test showed that there is a significant relationship between all the different 
scoring tools and sepsis. 
 
4.3 Prediction of mortality  
Three of 139 patients with sepsis died within 7-days and nine patients died within 30-days. 
Both SIRS and NEWS criteria were able to identify all these patients upon arrival at the ED. 
qSOFA did only identify one of three that died within 7-days.  
 
26 patients died within 1-year after admission. NEWS identified 20 of these patients 
compared to TILT that only identified 12.  
 
In total, 38 (27%) of the 139 patients died. Sensitivity for correctly identifying those 
experiencing mortality was 0.84 (95% CI: 0.70-0.93) for NEWS while qSOFA had highest 





With regards to sepsis related mortality, the AUC value for the different stratification tools 
was significantly higher using qSOFA than NEWS (p<0.001 and p<0.006). The AUC value 
for qSOFA was 0.71 (95% CI: 0.62-0.81) and 0.64 (95% CI: 0.55-0.73) for NEWS. 
Performance characteristics are presented in Figure 3 and Table 11. 
 
4.4 Modification of the different scoring systems 
Figure 4 shows an overview over patients’ risk factors. 23 of 139 patients with sepsis did not 
have any risk factors, 44 patients had one and 72 had two or more risk factors. 
 
Table 13 demonstrates the ability for the modified scoring systems to identify sepsis. The 
results show an increase in sensitivity for all the tools. qSOFA alone would have identified 67 
patients with sepsis, while the modified qSOFA identified 107 patients, given a new 
sensitivity of 0.77 (95% CI: 0.69-0.83). 118 patients would have fulfilled the new criteria of 
NEWS, with a new sensitivity of 0.85 (95% CI 0.78-0.90). 
 
5 Discussion  
5.1 Summary of findings 
In this retrospective study, NEWS had the best sensitivity for detecting sepsis and was of 
more clinical usefulness compared to qSOFA, SIRS and TILT. NEWS was also superior in 
predicting overall mortality in patients with sepsis admitted to the ED. SIRS showed a 
problematically low specificity in identifying sepsis. qSOFA detected few of the sepsis cases 
and had a poorer sensitivity than the other screening tools, which is in agreement with 
previous literature (67).  
 
When comparing the performance of the different risk stratification tools, qSOFA had the 
highest AUC value. Despite having a high AUC value, it should be stressed that the real 
characteristic of interest for clinical use are the sensitivity and specificity. Furthermore, we 
found that a modification of all four scoring systems by adding one point for risk factors, 
yielded a higher sensitivity. Our study is, to the best of our knowledge, the first to include risk 






5.2 Characteristics of sepsis patients at UNN   
In our retrospective study, 139 (52%) of the patients had sepsis according to sepsis-3 and 
UNN´s criteria for organ dysfunction. Despite a small study sample, the demographic 
characteristics are comparable with most sepsis studies (33, 68). We found that sepsis occurs 
more often in men than women. The higher occurrence of sepsis among men has been 
discussed in literature to be multifactorial. Studies have stated that factors like chronic health, 
behavioral factors and gender specific susceptibility to microbes, may be reasons why men 
are at higher risk (31, 69).  
 
Furthermore, we found that 68 patients with sepsis were older than 75 years. If we adjusted 
the age cutoff to 65 years, 94 patients would have been included. This shows that sepsis is 
more common among the elderly (70). Results from a Spanish study reported that the mean 
age of affected patients has increased during the past decades (71). The Norwegian sepsis 
report from 1999, reports a mean age of 58 years, whereas in a recent retrospective study it 
was 73 years (31, 32). This is in line with our observations.  
 
5.3 Sepsis definition   
In the present study, we chose to refer to the Sepsis-3 definition of sepsis. To identify patients 
with organ dysfunction, we used the local sepsis guideline at UNN (page 11). This was done 
in order to be able to diagnose sepsis at an early stage in a non-ICU environment. Similar has 
been done in a recent study by Knoop (31). The use of the Sepsis-3 definition of organ 
dysfunction in an ED setting, where the definition of organ dysfunction is represented by an 
increase in the SOFA scoring system, is highly debated (72). In the Sepsis-3 definition, it is 
only recommended and not required that organ dysfunction is based on a SOFA score  2. At 
present time, there is no international consensus concerning an optimal clinical scoring 
system to identify early organ dysfunction in sepsis patients in an emergency or prehospital 
setting and there is no gold standard diagnostic test that identify sepsis.  
 
In the revised Sepsis-3, qSOFA score is by several studies shown to be less sensitive in an 
emergency context when used as a screening tool (67, 72). The author of the Sepsis-3 study 
states that qSOFA should only be used as a quick bedside risk stratification tool to identify 
sepsis patients with high risk of poor outcome and should not rule out other screening tool for 
early sepsis identification. The author points out that qSOFA and SIRS criteria should be 




Furthermore, the full SOFA score is often used in an intensive care context and requires 
laboratory findings like PaO2, platelet count, creatinine level, and bilirubin level (2, 74). 
Some of these criteria are hard to obtain in an ED setting and therefore, we chose to use a less 
strict definition of organ dysfunction. Our modification may have given the possibility that 
our retrospective study is slightly biased towards a less severe patient group and makes it less 
comparable with other studies.  
 
5.4 Scoring systems / Scoring tools  
Many studies have analyzed and compared different scoring systems for identifying sepsis. 
Most studies have focused on SIRS and qSOFA (67, 75, 76) and few have compared these 
with NEWS (28). In the UK they use NICE guidelines to identify sepsis (62). To the best of 
our knowledge, nobody has done a comparison with TILT. Our findings suggest that no 
scoring systems had both high sensitivity and specificity in predicting those with sepsis in the 
ED. In an emergency setting, a sensitive tool is more important than a specific one. This is to 
avoid overlooking critically ill patients. Specificity might be more relevant in an ICU setting, 
to indicate whether a patient’s treatment should be escalated (18, 77).  
 
The SIRS criteria have been a part of the sepsis definition for more than two decades, and 
have been criticized in the literature for almost as long (12). One reason is that SIRS requires 
laboratory tests, and this may delay identification and treatment of sepsis (2). Furthermore, 
SIRS has been criticized for being oversensitive and may be present in many hospitalized 
patients, including those who never develop infection. Our results are consistent with other 
studies, also showing a problematically low specificity for SIRS (78-80). This indicates that 
having two or more elements of SIRS does not discriminate well enough for organ 
dysfunction.  
 
Recent studies have raised questions to the use of qSOFA as a bedside screening tool. Mainly, 
because it is shown to identify patients late, after organ dysfunction has occurred. In the 
present study, qSOFA failed as a clinical screening tool with a sensitivity of only 48%. This is 
supported by a study from Norway by Askim et al. where qSOFA only had a sensitivity of 
32% (67). Williams and colleagues reported a sensitivity of 29.9% (81). One reason qSOFA 
may fail to achieve high sensitivity may be due to not including important vital parameters 




In our study, we have used ROC curves to show in a graphic way the diagnostic performance 
for the different screening tools. The area under the ROC, AUC, gives an idea about the 
benefit of using the different tests. The AUC value is a measure of the usefulness in general. 
A weakness by using the AUC value is that it emphasizes sensitivity and specificity equally. 
Therefore, the severity of the disease is not considered. For a severe condition like sepsis, it is 
most important to use a screening tool with high sensitivity. Another way to use the ROC 
curve is to compare the result based on utility approaches to reach a different conclusion than 
only based on AUC. Our findings may have changed if a utility-based endpoint was used 
instead of AUC (65, 83). 
 
When comparing the performance of the different screening tools, the AUC value for qSOFA 
was higher than SIRS and NEWS. However, qSOFA had low sensitivity which highlights the 
limitations of using AUC alone when selecting a clinical screening tool. The consequent of 
using a screening tool with low sensitivity can be crucial when screening for sepsis, because 
of a high mortality rate. Despite a low sensitivity, qSOFA might be useful as a rapid and 
inexpensive tool to alert clinicians to further investigate the patients for organ dysfunction (2). 
 
In our study, NEWS had the highest sensitivity. This result is consistent with one study from 
the UK that compared NEWS to qSOFA and SIRS (18). Usman et al. have also reported that 
NEWS was most accurate for triage detection of sepsis with a sensitivity of 84% (28). Unlike 
SIRS, NEWS does not require any laboratory findings and is fully calculable at triage. 
Furthermore, NEWS incorporates a higher number of physiological parameters and offers a 
greater scoring flexibility compared to the other scoring systems. Even though it consists of 
several clinical measurements, an application has now been developed for smart phones that 
makes NEWS a practical and easy bedside screening tool (84).  
 
The NEWS review group has recommended a cutoff value of ≥ 5 when considering sepsis in 
patients with known or suspected infection (26). In the present study, we chose a cutoff value 
of ≥ 4, which is in line with guidelines from the Royal College of Physicians (85). The same 
cutoff value was also used in a study performed by Usman et al (28). The Royal College of 
Physicians recommend this threshold for separating low-risk patients from those who are at 
increased risk of developing sepsis (26). When testing with NEWS  5, the sensitivity 
decreased to 0.71 and the specificity increased to 0.69 (Table 7). Even though the cutoff value 




choosing a scoring tool, it is important to have in mind that a good sensitivity would identify 
more patient with potential sepsis, but at the same time lead to some overtreatment. 
 
At UNN, they use TILT as a tool to assess and monitor the clinical condition of hospital 
patients in the wards. In this study, we wanted to investigate whether the already implemented 
tool in-hospital could be used as a model in predicting those with sepsis in an ED setting. Our 
results suggest that TILT is not sensitive enough as a replacement for already existing 
screening tools in the ED at UNN. Many institutions in Europe are now routinely using 
NEWS for early detection of patients at risk for deterioration. Some have also implemented it 
as a sepsis tool. Our results showed promising benefits of using NEWS in detection of sepsis. 
This is supported by two recent published studies (18, 28).  
 
Results from the second evaluation in the ED at UNN from 2018, revealed that the majority 
of patients with sepsis were identified and received treatment within time (13). Our results 
add further to the debate about the clinical usefulness of different scoring systems. Currently, 
they use both qSOFA and SIRS when screening for sepsis. The present study shows that 
NEWS performed better than qSOFA and SIRS. UNN should consider whether there is any 
clinical benefit in adopting NEWS as both standardized clinical chart in-hospital and as a 
screening tool for sepsis (18). One can argue if a common scoring system like NEWS could 
support communication between healthcare professionals. 
 
5.5 Risk factors  
This thesis explores the concept of adding risk factors to the different scoring systems. 
Interestingly, we found that a modification of the scoring systems yield a higher sensitivity 
for all four scoring systems. It increased significantly for qSOFA, but did not add much to the 
performance of NEWS. qSOFA has been challenged as a screening tool in the ED despite its 
high specificity and low sensitivity. By adding risk factors, it performed better. One can 
therefore argue that the modified qSOFA score could offer an effective method for early 
detection of sepsis, since it can easily be assessed and quickly repeated. Our results prove that 






There is evidence, that age is a risk factor for developing sepsis mainly because the elderly 
often have more comorbidities (70, 86). The current study does also support that age is an 
important risk factor. When considering cutoff, we used the age of 75 years as recommended 
in UNN´s criteria. Previous studies have recommended a cutoff at 65 years (86). In our study, 
we found that 68 patients with sepsis were over 75 years and 94 patients were over 65 years. 
By lowering the age limit to 65 years, 26 more patients would have been detected with sepsis. 
Results from our study highlights the importance of including risk factors and prompt the 
attention to the elderly when screening for sepsis.  
 
A study by Martin and colleagues have found that age is an independent risk factor for 
determining the risk for sepsis (86). With this is mind, it would be interesting to conduct a 
similar study by adding two new parameters to the different scoring system where age is an 
independent risk factor.  
 
5.6 Mortality 
This study demonstrates that sepsis is associated with both short- and long-term mortality. We 
observed that one in 15 died within 30-days and that almost one in five died within 1-year. 
Our findings highlight the negative effects and consequences of sepsis. Studies have shown 
that patients suffering from sepsis have increased mortality and that those surviving sepsis 
might suffer from cognitive impairment and functional disability for years after 
hospitalization (87, 88). This is also illustrated in a systematic review by Winters et al. (88).  
 
Regarding 1-year mortality, our findings are consistent with those from Wang et al. Results 
from their study demonstrated that individuals with sepsis had an increased rate of long-term 
death, even after accounting for comorbidities (89). They also found that sepsis is 
independently associated with increased mortality risk with a 1-year mortality of 23 %. It is 
important to have in mind that these results can be biased since the patient also can die from 
other causes. 
 
In the present study, NEWS had the best sensitivity for predicting mortality. Even though our 
findings are based on a small number of participants, our results reflect the same outcome as 
in a larger study by Churpek et al. They presented and concluded that NEWS had the best test 






AUC values for the different scoring systems in prediction of mortality are higher in our study 
compared with those reported by Goulden et al. We found that qSOFA had a relatively high 
AUC value compared with the other tools. Recently, two studies also confirmed a high 
prognostic ability of qSOFA to predict mortality (76, 90). Even though, qSOFA preformed 
the best in our study, the AUC value for NEWS is in line with those reported by Goulden and 
colleagues (18). 
 
Regarding the AUC results, it is important to stress that scoring tools are meant to be used in 
a clinical setting and therefor the sensitivity and specificity are of real interest instead of the 
overall accuracy. By using a high sensitivity tool, like NEWS, it is more likely to early 
identify patients at risk and provide early treatment and maybe improve outcome 
 
5.7 Strengths and limitations 
This study has a number of limitations. Firstly, it is a retrospective study which may increase 
the risk for misclassification, biases and confounding. Secondly, the study was performed at a 
single-center teaching hospital in Northern Norway. Larger multi-center prospective studies 
are needed to validate our results. Thirdly, our study sample was limited by the number of 
patients included and mainly consisting of Caucasians.  
 
Furthermore, our inclusion criteria were strict and may present as a bias. We may have missed 
some patients by not screening all ED admissions. We only included patients who either were 
received by the medical team or those who later were admitted to the Department of Infection. 
However, we chose this approach because we aimed to determine the prognostic value of the 
different scoring tools. This patient group was thought to be more representative for our aim 
because they are more likely to have an infection and therefore at higher risk of developing 
sepsis.  
 
Due to a lack of standardized documentation by the doctor, we found it challenging to 
determining the patients´ mental status when we retrospectively collected data. Further we 
found it difficult to evaluate the altered mental status in certain patients’ group like those with 




Since Sepsis-3 only recommends that organ dysfunction should be based on a SOFA score 
2, we chose to use a minor modification because the use of SOFA score in a non-ICU is 
difficult. The use of a local definition of organ dysfunction makes it challenging for other 
studies to compare their findings with our results. Furthermore, we did not classify and 
categorize each individual organ dysfunction, neither how many organ systems that were 
affected. Therefore, we could not analyze the degree of the organ dysfunction or if the 
mortality was associated with certain organ systems. 
 
A weakness in our study design is that we chose not to specify which type of risk factors the 
patient had. Because of this, we could not estimate which risk factor that had the strongest 
association with the development of sepsis. In the present study, we added one point to each 
scoring system if the patient had one or more of the defined risk factors. It would have been 
of interest to see if an increased cutoff limit (2 or more risk factors) would have affected the 
result.  
 
The main strength in this study, is that the first vital parameter recorded at the time of arrival 
at the ED were used to screen patients for sepsis. A study by Seymour and others, included a 
24 hours collection of vital parameters to calculate qSOFA. They also choose to record the 
worst value of qSOFA score during the same period. This could have biased their results to a 
higher qSOFA score. We chose a more realistic approach, which actually reflects the clinical 
practice at the ED. This is in our opinion a valid method to test predictive performance to the 
different scoring systems. However, one can argue that this might also be a limitation as we 
are aware that sepsis can develop rapidly and a sudden change in vital parameter occurs 
quickly. Another strength is that by excluding patients who received prehospital treatment 
with antibiotics, we limited the effect of confounding actions by clinicians.  
 
 
6 Conclusion  
 
This retrospective study from the ED at UNN, showed that all scoring systems included in the 
study were able to recognize patients with sepsis. In conclusion, NEWS was found to be of 
more clinical usefulness compared to qSOFA, SIRS and TILT in early identification of sepsis. 
NEWS is at least equivalent or better than the other screening tools across most measures in 
predicting mortality. Our finding suggests that the implementation of risk factors in different 




using a highly sensitive and easy calculable scoring system, it is important to remember that a 
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Appendix 1 Tables 
 
Table 1                                                  SIRS criteria (≥ 2) 
Body temperature > 38.0 °C or < 36.0 °C 
Heart rate  > 90/min 
Respiratory rate > 20 breaths/min or PaCO2 4.3 kPa in arterial blood gas analysis 
White blood cell count < 4000 /cu mm or > 12,000 cells/mm3 
 
 
Table 2                                               qSOFA score (≥ 2) 
Respiratory rate ≥ 22 breaths/min 
Central nervous system Alteration in mental status 
Systolic blood pressure ≤ 100 mmHg 
 
 
Table 3                                                                                TILT (≥ 4) 
 Score 












<70 71-80 81-100 101-199  ≥220  
Temperature  
(°C) 
 <35.0 35.1-36.0 36.1-38.0 38.1-38.5 ≥38.5  





















3 2 1 0 1 2 3 
Respiration 















        
Saturation SpO2 
(%) SCALE 1 




























































91-110 111-130 ≥131 
Consciousness    Alert   CVPU 
Temperature 
 
≤35.0  35.1-36.0 36.1-38.0 38.1-39.00 ≥39.1  










0 1 2 3 4 
Respiration 








































































≥ 70 mmHg 
 
MAP 















> 15 or 
epinephrine 
 > 0.1 or 
norepinephrine  
> 0.1A 
Abbreviations: A Adrenergic agents (µg/kg/min) given for at least 1 hour, MAP; mean arterial pressure. FiO2; fraction of inspired oxygen, PaO2; partial pressure 
of oxygen 
 
Table 6                                                    Study sample characteristics 
 
 










 Male, n (%) 151 (56) 86 (57) 24 (16) 
 Female, n (%) 119 (44) 53 (45) 14 (12) 
 Patients <75 years, n (%) 173 (64) 71 (41) 14 (8) 
 Patients ≥75 years, n (%) 
 
97 (36) 68 (70) 24 (25) 
 
 Patients <65 years, n (%)  (64) 71 (41) 14 (8) 
 Patients ≥65 years, n (%) (64) 71 (41) 14 (8) 
All patients, n (%) 270 (100) 139 (51) 38 (27) 
Age in years, mean 
(median) 
64 (69) 67 (73) 74 (79) 
    









Table 7 The ability of the different screening tool to identify patients with sepsis in the 




Ability to identify 
sepsis 















SIRS ≥ 2 106 (76.3%) 0.76 (0.69-0.83) 0.47 (0.38-0.55) 
TILT ≥ 4 81 (58.3%) 0.58 (0.50-0.66) 0.77 (0.69-0.83) 
NEWS ≥ 4 109 (78.4%) 0.78 (0.71-0.84) 0.59 (0.50-0.67) 
NEWS ≥ 5 99 (71.2%) 0.71 (0.63-0.78) 0.69 (0.60-0.76) 
Abbreviations: CI; Confidence Interval., n = 139 cases of sepsis among 270 patients 


























0.66 – 0.78 
 
 
SIRS ≥ 2 0.61 0.03 0.00 0.55 – 0.68  
TILT ≥ 4 0.68 0.03 0.00 0.61 – 0.74   
NEWS ≥ 4 0.69 0.03 0.00 0.62 – 0.75  
a Under the nonparametric assumption, b Null hypothesis: true area = 0.5 




















8.00 – 46.93 
 
 
SIRS ≥ 2 106 2.80 1.66 – 4.71  
TILT ≥ 4 81 4.70 2.77 – 7.99  
NEWS ≥ 4 109 5.20 3.04 – 8.84  























      
7-days mortality 
(n=3) 
qSOFA ≥ 2  1 (33.3%) 0.33 (0.06-0.79) 0.51 (0.43-0.60)  
 SIRS ≥ 2 3 (100.0%) 1.00 (0.44-1.00) 0.24 (0.18-0.32)  
 TILT ≥ 4 3 (100.0%) 1.00 (0.44-1.00) 0.43 (0.35-0.51)  
 NEWS ≥ 4 3 (100.0%) 1.00 (0.44-1.00) 0.22 (0.16-0.30)  
30-days mortality 
(n=9) 
qSOFA ≥ 2  6 (66.7%) 0.67 (0.35-0.88) 0.53 (0.45-0.61)  
 SIRS ≥ 2 9 (100.0%) 1.00 (0.70-1.00) 0.25 (0.19-0.33)  
 TILT ≥ 4 7 (77.8%) 0.78 (0.45-0.94) 0.43 (0.35-0.52)  
 NEWS ≥ 4 9 (100.0%) 1.00 (0.70-1.00) 0.23 (0.17-0.31)  
1-year mortality 
(n=26) 
qSOFA ≥ 2  17 (65.4%) 0.65 (0.46-0.81) 0.56 (0.47-0.65)  
 SIRS ≥ 2 16 (61.5%) 0.62 (0.43-0.78) 0.20 (0.14-0.29)  
 TILT ≥ 4 12 (46.2%) 0.46 (0.29-0.65) 0.39 (0.30-0.48)  
 NEWS ≥ 4 20 (76.9%) 0.77 (0.58-0.89) 0.21 (0.15-0.30)  
Death in total 
(n=38) 
qSOFA ≥ 2  24 (63.2%) 0.63 (0.47-0.77) 0.57 (0.48-0.67) 0.71 (0.62-0.81) 
 SIRS ≥ 2 28 (73.7%) 0.73 (0.58-0.85) 0.22 (0.16-0.32) 0.55 (0.45-0.65) 
 TILT ≥ 4 22 (57.9%) 0.58 (0.42-0.72) 0.42 (0.32-0.51) 0.60 (0.50-0.70) 
 NEWS ≥ 4 32 (84.2%) 0.84 (0.70-0.93) 0.24 (0.17-0.33) 0.64 (0.55-0.73) 
Sensitivity, Specificity, for sepsis by different modified screening tools in the ED  



































0.62 – 0.81 
 
 
SIRS ≥ 2 0.55 0.05 0.33 0.45 – 0.65  
TILT ≥ 4 0.60 0.05 0.05 0.50 – 0.70  
NEWS ≥ 4 0.64 0.04 0.01 0.55 – 0.73  
a Under the nonparametric assumption 


























































Table 13  The ability for the different modified screening tool to identify patients with sepsis in 












m-qSOFA ≥ 2  107 (77.0%) 0.77 (0.69-0.83) 0.69 (0.61-0.77) 
m-SIRS ≥ 2 129 (92.8%) 0.93 (0.87-0.96) 0.29 (0.22-0.37) 
m-TILT ≥ 4 97 (69.8%) 0.70 (0.62-0.77) 0.65 (0.56-0.73) 
m-NEWS ≥ 4 118 (84.9%) 0.85 (0.78-0.90) 0.49 (0.40-0.57)  






Appendix 2 Figures 
 
 








Included, n = 270
No sepsis, n = 131 Sepsis, n = 139
qSOFA ≥ 2, n = 67 SIRS ≥ 2, n = 106
NEWS ≥ 4, n = 109
NEWS ≥ 5, n = 99
TILT ≥ 4, n = 81
TILT ≥ 5, n = 50
TILT ≥ 6, n = 28





Figure 2  ROC curves for the different scoring systems in prediction of screening for sepsis, n 
         
  
 
Abbreviations: AUC=Area under the reciver operating charateristic, ROC =Receiver operating characteristic 













Figure 3   ROC curves for the different scoring systems in prediction of total mortality, n 
         
 
  
 Abbreviations: AUC=Area under the reciver operating charateristic, ROC =Receiver operating characteristic 
n = 38 cases of mortality among 139 patients with sepsis 














Appendix 3 Gradings 
Referance:  
O.A. Usman, A.A. Usman and M.A. Ward, Comparison of SIRS, qSOFA, and NEWS for the early identification of sepsis in the 
Emergency Department, American Journal of Emergency Medicine, https://doi.org/10.1016/j.ajem.2018.10.058 
GRADE  
Class of Evidence (CoE)   II 
Recommendation  B 
Objective Material and method  Results Discussion  
This study reviewed 
the viability of NEWS 
as an early predictor of 
severe sepsis and septic 
shock (SS/SS) in an 
ED triage setting and 
evaluated its 
performance against 
SIRS and qSOFA. 
Study design:  
A retrospective analysis 
Study population 
The study consisted of 130.595 ED patients.  
115.734 were included. 930 cases of SS/SS 
were identified. 14.861 were excluded.  
Inclusion criteria:  
 Adult (age ≥ 18 years) visiting the 
ED 
 The study population was based on 
the presence of SS/SS within 8 h of 
ED arrival  
 All ED patients with ICD-9 or 
ICD-10 codes related to sepsis and 
clinical concern or infection 
 Flagged patients with orders for 
blood cultures, urine cultures, or 
antibiotics within 12 h of ED 
arrival 
Exclusion criteria: 
 Patients lacking adequate clinical 
evaluation 
 Patients with a ventricular assist 
device (n=14,861, 11.4%) 
Statistic methods: 
Data analysis was conducted in R 
Foundation for Statistical Computing, 2017. 
Predictive ability was compared using 
AUROC. Sensitivities and specificities are 
reported with 95% Confidence Intervals (CI) 
using the Wilson Score interval.  
NEWS was most accurate for triage detection of SS/SS 
(AUROC, 0.91, 0.88, 0.81), septic shock (AUROC, 0.93, 0.88, 
0.84), and sepsis-related mortality (AUROC,  0.95, 0.89, 0.87) 
for NEWS, SIRS, and qSOFA, respectively  
For the detection of SS/SS (95% CI), sensitivities were 84.2% 
(81.5–86.5%), 86.1% (83.6–88.2%), and 28.5% (25.6–31.7%) 
and specificities were 85.0% (84.8–85.3%), 79.1% (78.9–
79.3%), and 98.9% (98.8–99.0%) for NEWS ≥ 4, SIRS ≥ 2, 
and qSOFA ≥ 2, respectively. 
Checklist: 
- Are the groups comparable in relation to important background 
factors? Only one group 
- Are the groups recruited from the same section of the 
population? Yes 
- Were the exposed individuals representative for a defined 
section of the population? Yes 
- Was the study prospective? No 
- Were exposure and outcome measured equal and reliable? 
Unknown 
- Were sufficient number of persons in the study followed up? 
Yes 
- Is it performed drop out analyses? No 
- Was the follow up time lengthy enough to prove positive 
and/or negative outcomes? Yes 
- Are important confounding factors in design/implementation 
considered? No 
- Was the person who evaluated the results (end points) blinded 
group identification? No 
Strength: 
-Easy adaptable inclusion and exclusion criteria. -A large study 
population 
-The study was done based on values available at the time of 
triage 
Limitations: 
-The study was retrospective 
-Single-center study with a predominately African-American 
population   
-The study was unblended 
-The results was  based on the Sepsis-2 guidelines, which may 
result in an incorporation bias favoring SIRS 
Conclusion 
NEWS is more 
accurate than both 
SIRS and qSOFA  
for the detection of all 
sepsis endpoints. 
NEWS was more 
specific with similar 
sensitivity relative to 
SIRS. 
qSOFA had the lowest 
sensitivity and is a 
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GRADE  
Class of Evidence (CoE)   IIb 
Recommendation  B 
Objective Material and method  Results Discussion  
To compare the accuracy 
of qSOFA as an early 
warning score with SIRS, 
MEWS, and NEWS in 
patients with suspected 
infection on the wards 
and in the ED for 
predicting adverse 
outcomes. 




150,288 identified, 30,677 analyzed 
47% male.  
Mean age: 58 years old (SD 18.0) 
 
Inclusion criteria:  




Patients without vital sign or laboratory data 
documented in the ED or wardsPatients who 
received mechanical ventilation or vasopressor 
medications before the first suspicion of infection 
 
Statistic methods: 
Patient characteristics were compared using: 
 t tests, Wilcoxon rank sum tests and χ2 
tests 
Accuracy comparisons were performed using: 
 Sensitivity, specificity, (AUC) 




Stata (version 14.1; StataCorp, College Station, 
TX). 
Founding:  
University of Chicago 
The primary outcome: in-hospital mortality. 
Secondary outcome: the composite of death or ICU stay 
after a patient met the suspicion of infection criteria. 
 
30,677 patients were included. 1,649 (5.4%) died and 7,385 




 60% (n = 18,523) met the suspicion criteria in the 
ED 
 NEWS had the best AUC value for in-hospital 
mortality, (AUC, 0.77; 95% CI, 0.76–0.79), 
followed by MEWS (AUC, 0.73; 95% CI, 0.71–
0.74), qSOFA (AUC, 0.69; 95% CI, 0.67–0.70), 
and SIRS (AUC, 0.65; 95% CI, 0.63–0.66)  
 
Secondary outcome: (Using the highest non-ICU score of 
patients): 
 SIRS ≥2: sensitivity of 91% and specificity of 
13% 
 qSOFA ≥2: sensitivity 54% and specificity 67%,  
 MEWS ≥5: sensitivity 59% and specificity 70%,  
 NEWS ≥8: sensitivity 67% and specificity 66% 
 
Most patients met ≥2 SIRS criteria 17 hours before the 
combined outcome compared with 5 hours for ≥2 and 17 
hours for ≥1 qSOFA criteria. 
 
Checklist: 
- Are the groups comparable in relation to important 
background factors? Only one group 
- Are the groups recruited from the same section of the 
population? Yes 
- Were the exposed individuals representative for a defined 
section of the population? Yes 
- Was the study prospective? No 
- Were exposure and outcome measured equal and reliable? 
Unknown 
- Were sufficient number of persons in the study followed 
up? Yes 
- Is it performed drop out analyses? Yes 
- Was the follow up time lengthy enough to prove positive 
and/or negative outcomes? Yes 
- Are important confounding factors in 
design/implementation considered? Not recorded 
- Was the person who evaluated the results (end points) 
blinded group identification? No 
 
Strength: 
-Large study sample 
-Easy adaptable inclusion and exclusion criteria 
 
Limitations: 
-Single-center study in an academic U.S. hospital, so the 
results may not be generalizable 
-Handling of missing data: 66% of admissions were excluded 
due to missing data 
-No clear definition of sepsis (selection bias). May have 
excluded patients with sepsis and included others who were 
not. 
Conclusion 
SIRS, MEWS, and 
NEWS are more accurate 
than the qSOFA score for 
predicting death and ICU 
transfer in non-ICU 
patients. These results 
suggest that qSOFA 
should not replace 
general early warning 
scores when risk-
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GRADE  
Class of Evidence 
(CoE)  
 IIb 
Recommendation  B 
Objective Material and method  Results Discussion  
To evaluate the 
prognostic accuracy of 
qSOFA, SIRS and NEWS 
for predicting inhospital 
mortality and ICU 
admission in the ED  
Study design:  
Retrospective cohort 
 
Study population: n=1818  
 
Inclusion criteria:  
 All adult patients presenting to the ED or medical admissions unit 
(MAU) with suspicion of or treated for sepsis  
 All those who had a sepsis form completed 
 
Main clinical outcome: 
 The primary outcome: inhospital mortality 




Predicting inhospital mortality and ICU admission: 
 Sensitivity, specificity  
 AUROC, positive  
 PPV 
 NPV 
 Negative likelihood ratio was calculated for each scoring system 
 
The sensitivity and spcificity for the primary outcome were compared using 
McNemar’s test. 
The AUROC was compared using DeLong’s method.  
Missing data: 
Missing information in the different scoring tool in the electronic form was 
recorded manually. For those still missing values of the scoring systems, 
missingness was predicted by other variables by using logistic regression 
Statistical analyses: 
Stata V.15.0 (Stata, College Station, Texas, USA) 
 
Among 1818 patients, 53 were admitted to 
ICU (3%) and 265 died in hospital (15%).  
 
AUC for inhospital mortality: 
NEWS≥5 (65%, 95% CI 61% to 68%) 
qSOFA≥2 (62%, 95% CI 59% to 66%)  
 
The sensitivity inhospital mortality: 
NEWS≥5 (74%, 95% CI 68% to 79%) 
SIRS≥2 (80%, 95% CI 74% to 84%) 
qSOFA≥2 (37%, 95% CI 31% to 43%)  
 
The specificity inhospital mortality: 
NEWS≥5 (43%, 95% CI 41% to 46%)  
SIRS≥2 (21%, 95% CI 19% to 23%)  
qSOFA≥2 (79%, 95% CI 77% to 81%)  
 
The negative predictive value inhospital 
mortality: 
NEWS≥5 (91%, 95% CI 88% to 93%) 
SIRS≥2 (86%, 95% CI 82% to 89%)   





- Are the groups comparable in relation to 
important background factors? Only one group 
- Are the groups recruited from the same section 
of the population? Yes 
- Were the exposed individuals representative for a 
defined section of the population? Yes 
- Was the study prospective? No 
- Were exposure and outcome measured equal and 
reliable? Unknown 
- Were sufficient number of persons in the study 
followed up? Yes 
- Is it performed drop out analyses? Yes 
- Was the follow up time lengthy enough to prove 
positive and/or negative outcomes? Yes 
- Are important confounding factors in 
design/implementation considered? Not recorded 
- Was the person who evaluated the results (end 
points) blinded group identification? No 
 
Strength: 
-Their results are consistent with other studies 
-Preformed missing data analysis 
 
Limitations: 
- Lack of data on patient comorbidities and cause 
of death, limiting the ability to determine the 
specific role of sepsis 
-Retrospective study 
-Single center study 
Conclusion 
NEWS has equivalent or 
superior value for most 
test characteristics 




Year of data collection 





Askim A, Moser F, Gustad LT, Stene H, Gundersen M, Asvold BO, et al. Poor performance of quick-SOFA (qSOFA) score in predicting severe sepsis and mortality - a 
prospective study of patients admitted with infection to the emergency department. Scandinavian journal of trauma, resuscitation and emergency medicine. 2017;25(1):56. 
GRADE 
Class of Evidence (CoE)   IIb 
Recommendation  B 
Objective Material and methods  Results Discussion 
To evaluate the 
clinical usefulness of 
qSOFA to predict 
severe sepsis and 7- 
and 30-day mortality 
and compare its 
performance to SIRS 
criteria and the Rapid 







The study consisted of 
1568 ED patients 
 
Inclusion criteria 
 All patients ≥16 years 
of age with a new onset 
of suspected or 
confirmed infection 
according to the 
(ESS47).  
 Patients with the 4 
highest acuity 
levels according to the 
Rapid Emergency 




 Patients that left the ED 
before registration or 
had no identification. 




The data was analyzed 
using Stata version 13. 
The ROC and logistic 
regression analysis after 
MI were compared with 




Of the 1535 admitted patients, 108 (7.0%) fulfilled the Sepsis2 criteria for severe sepsis. The qSOFA score ≥2 identified only 33 
(sensitivity 0.32, specificity 0.98) of the patients with severe sepsis, while the RETTS-alert ≥ orange identified 92 patients (sensitivity 
0.85, specificity 0.55).  
Sensitivity, Specificity, and Positive (PPV) and Negative Predictive Values (NPV) for severe sepsis by different identification tools in the Emergency 
department (n = 108 cases of severe sepsis among 1535 patients) 
Identification tool Severe sepsis Sensitivity Specificity PPV NPV 
n (% of 108 cases) (95% CI) (95% CI) (95% CI) (95% CI) 
SIRS ≥2 (-leukocytes) 80 (74.1%) 0.74 (0.65-0.82) 0.72 (0.70-0.75) 0.18 (0.16-0.19) 0.97 (0.96-0.98) 
qSOFA ≥2a 33 (30.6%) 0.32 (0.23-0.42) 0.98 (0.97-0.99) 0.57 (0.45-0.68) 0.95 (0.94-0.96) 
Red triage 37 (34.3%) 0.34 (0.25-0.44) 0.95 (0.94-0.96) 0.35 (0.27-0.43) 0.95 (0.94-0.95) 
Orange triage 55 (50.9%) 0.51 (0.41-0.61) 0.60 (0.58-0.63) 0.09 (0.07-0.11) 0.94 (0.93-0.95) 
≥ Orange triage 92 (85.2%) 0.85 (0.77-0.91) 0.55 (0.52-0.58) 0.13 (0.12-0.14) 0.98 (0.97-0.99) 
Twenty-six patients died within 7 days of admission; four (15.4%) of them had a qSOFA ≥2, and 16 (61.5%) had RETTS ≥ orange alert.  
Sensitivity, Specificity, and Positive (PPV) and Negative Predictive Values (NPV) for 7-day mortality by different stratification tools in the Emergency 
Department (n = 26 cases of deaths within 7 days among 1535 patients) 
Stratification tool Died within 7 days Sensitivity Specificity PPV NPV 
n (% of 26 cases) (95% CI) (95% CI) (95% CI) (95% CI) 
Severe sepsis 8 (30.8%) 0.31 (0.14-0.52) 0.93 (0.92-0.94) 0.07 (0.04-0.12) 0.98 (0.98-0.98) 
SIRS ≥2 17 (65.4%) 0.65 (0.44-0.82) 0.55 (0.52-0.57) 0.03 (0.02-0.03) 0.99 (0.98-0.99) 
SIRS ≥2 (-leukocytes) 15 (57.7%) 0.58 (0.36-0.76) 0.70 (0.67-0.72) 0.03 (0.02-0.04) 0.99 (0.98-0.99) 
qSOFA ≥2 4 (15.4%) 0.16 (0.05-0.36) 0.96 (0.95-0.97) 0.07 (0.03-0.15) 0.98 (0.98-0.99) 
Red triage 8 (30.8%) 0.31 (0.14-0.51) 0.93 (0.91-0.95) 0.07 (0.04-0.12) 0.99 (0.98-0.99) 
Orange triage 8 (30.8%) 0.31 (0.14-0.52) 0.60 (0.58-0.63) 0.01 (0.00-0.02) 0.98 (0.98-0.99) 
≥ Orange triage 16 (61.5%) 0.62 (0.41-0.80) 0.53 (0.51-0.56) 0.02 (0.01-0.03) 0.99 (0.98-0.99) 
Of the 68 patients that died within 30 days, 8 (11.9%) scored ≥2 on the qSOFA, and 45 (66.1%) had a RETTS ≥ orange alert. 
Sensitivity, Specificity, and Positive (PPV) and Negative Predictive Values (NPV) for 30-day mortality by different stratification tools in the Emergency 
Department (n = 68 cases of deaths within 30 days among 1535 patients) 
Stratification tool Ability to identify those who died Sensitivity Specificity PPV NPV 
n (% of 68 cases) (95% CI) (95% CI) (95% CI) (95% CI) 
Severe sepsis 19 (27.9%) 0.29 (0.18-0.41) 0.94 (0.92-0.95) 0.18 (0.12-0.24) 0.96 (0.95-0.97) 
SIRS ≥ 2 42 (61.8%) 0.64 (0.51-0.75) 0.55 (0.53-0.58) 0.06 (0.05-0.07) 0.97 (0.96-0.98) 
SIRS ≥ 2 (-leucocytes) 32 (45.6%) 0.48 (0.36-0.61) 0.70 (0.68-0.72) 0.07 (0.05-0.08) 0.97 (0.96-0.97) 
qSOFA ≥2 8 (11.9%) 0.13 (0.05-0.25) 0.96 (0.95-0.97) 0.14 (0.07-0.23) 0.96 (0.96-0.96) 
Red triage 14 (20.2%) 0.21 (0.12-0.32) 0.94 (0.92-0.95) 0.13 (0.08-0.19) 0.96 (0.96-0.96) 
Orange triage 31 (45.6%) 0.46 (0.22-0.58) 0.61 (0.58-0.63) 0.05 (0.04-0.07) 0.96 (0.95-0.97) 
















The odds ratio (OR) for severe sepsis in the qSOFA ≥ 2 category (24.4, 95% CI 13.243.2) compared with the red triage group (9.7, 95% 
CI 6.115.5). Among the different identification tools, red triage and severe sepsis had the highest odds ratios for 7-day and 30-mortality. 
Checklist: 
- Are the groups comparable in relation 
to important background factors? Not 
two groups of cases 
- Are the groups recruited from the 
same section of the population? Yes 
- Were the exposed individuals 
representative for a defined section of 
the population? Yes 
- Was the study prospective? Yes 
- Were exposure and outcome measured 
equal and reliable? Unknown 
- Were sufficient number of persons in 
the cohort followed up? Yes 
- Is it performed drop out analyses? No  
- Was the follow up time lengthy 
enough to prove positive and/or 
negative outcomes? Yes 
- Are important confounding factors in 
design/implementation considered? No 
- Was the person who evaluated the 
results (end points) blinded group 
identification? Not relevant 
 
Strengths: 
-Easy adaptable inclusion and exultation 
criteria 
-A large study population 
-The study is the fourth study were 
qSOFA finds few of the sepsis cases in 
prehospital or at arrival to the ED 
 
Limitations: 
-The study was a single-center study 
-The study was unblinded 
-Lack of information on cormorbidities  
Conclusion 
qSOFA failed to 
identify two thirds of 
the patients admitted 
to the ED with severe 
sepsis. qSOFA failed 
to be a risk 
stratification tool as 
the sensitivity to 
predict 7-day and 30-
day mortality was low.  
The sensitivity was 
poorer than RETTS-
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GRADE 




Objective Material and methods  Results Discussion 
1. Determine the prognostic 
impact of SIRS 
2. Compare the diagnostic 
accuracy of SIRS and 
qSOFA for organ 
dysfunction 
3. Compare standard (Sepsis-2) 
and revised (Sepsis-3) 
definitions for organ 






The study consisted of 8871 ED patients 
 
Inclusion criteria 
 Patients aged < 17  
 Patients with infection or 
suspected infection in the ED 
 
Exclusion criteria 




Analyses were performed using Stata, 















SIRS was associated with increased risk of organ dysfunction 
(relative risk (RR) 3.5) and mortality in patients without organ 
dysfunction (OR 3.2).  
 
SIRS and qSOFA showed similar discrimination for 
organ dysfunction (area under the receiver operating characteristic 
curve, 0.72 vs 0.73).  
qSOFA was specific but poorly sensitive for organ dysfunction 
(96.1% and 29.7%, respectively). 
 
Mortality for patients with organ dysfunction was similar for Sepsis-
2 and Sepsis-3 (12.5% and 11.4%, respectively), although 29% of 
patients with Sepsis-3 organ dysfunction did not meet Sepsis-2 
criteria. Increasing numbers of Sepsis-2 organ system dysfunctions 
were associated with greater mortality. 
Checklist: 
- Are the groups comparable in relation to important 
background factors? Not two groups of cases 
- Are the groups recruited from the same section of the 
population? Yes 
- Were the exposed individuals representative for a 
defined section of the population? Yes 
- Was the study prospective? No 
- Were exposure and outcome measured equal and 
reliable? Unknown 
- Were sufficient number of persons in the cohort 
followed up? Yes 
- Is it performed drop out analyses? No  
- Was the follow up time lengthy enough to prove 
positive and/or negative outcomes? Yes 
- Are important confounding factors in 
design/implementation considered? No 
- Was the person who evaluated the results (endpoints) 
blinded group identification? Not relevant  
 
Strengths: 
 Easy adaptable inclusion and exclusion criteria. 
A large study population and reliable national 
database. 
 The study is the first assessment of the proposed 
Sepsis-3 criteria in the ED   
Limitations: 
 The methods used to identify patients may not 
have identified all ED patients with infection 
 Included patients may not have had an infection 
 Single-center study 
Conclusion 
SIRS was associated with organ 
dysfunction and mortality. A 
qSOFA score ≥ 2 showed high 
specificity, but poor sensitivity. 
Mortality for organ dysfunction 
was comparable between 
Sepsis-2 and Sepsis-3. 
Country 
Australia 
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Objective Material and methods  Results Discussion 
To determine the 
diagnostic accuracy of 
the qSOFA criteria in 
predicting mortality in 
ED patients with 
infections and 
compared the 
performance with that 






Eight studies with a total of 52,849 
patients were included 
 
Search strategy 
PubMed, EMBASE and Google 
Scholar (up to April 2018) were 
searched for related articles 
 
Inclusion criteria 
 ED patients with infections 
 Clear diagnostic reference 
standard for infection was 
used 
 The study purpose had to 
evaluate or compare the 
prognostic value of qSOFA 
and SIRS in predicting death 
within the same patient 
population 
 Adequate information to 
perform true positives, false 
positive, false negatives and 
true negatives test 
 
Exclusion criteria 
 Review articles  
 Letters 
 Conference abstracts 
 Expert opinions 
All studies indicated that a qSOFA score ≥ 2 was associated with a high risk 
of mortality in ED patients with infections, with a pooled risk ratio (RR) of 
4.55 (95% CI, 3.38-6.14) using a random-effects model (I2 = 91.1%).  
 
 
A SIRS score ≥ 2 was a prognostic marker of mortality in ED patients with 
infections, with a pooled RR of 2.75 (95% CI, 1.96-3.86) using a random-
effects model (I2 = 89%).  
 
 
When comparing the performance of qSOFA and SIRS in predicting 
mortality, a qSOFA score ≥ 2 was more specific; however a SIRS score ≥ 2 
was more sensitive. The initial qSOFA values were of limited prognostic 
value in ED patients with infections. 
 
 
Pooled performance characteristics of qSOFA and SIRS criteria for predicting mortality 
in ED patients with infections 



























3 (2–4) 0.70 (0.65–
0.73) 
Checklist: 
- Are the groups comparable in relation to important background 
factors? Yes 
- Are the groups recruited from the same section of the 
population? No 
- Were the exposed individuals representative for a defined 
section of the population? Yes 
- Was the study prospective? No 
- Were exposure and outcome measured equal and reliable? Yes 
- Were sufficient number of persons in the study followed up? 
Yes 
- Is it performed drop out analyses? No  
- Was the follow up time lengthy enough to prove positive 
and/or negative outcomes? Yes 
- Are important confounding factors in design/implementation 
considered? Yes 
- Was the person who evaluated the results (endpoints) blinded 
group identification? Not relevant 
Strengths: 
-Easy adaptable inclusion and exclusion criteria.  
-All the studies included are from 2017-2018 
-Used data from PubMed, EMBASE and Google Scholar. 
-Fairly equal consensus of variables across countries/continents. 
Limitations: 
-A small number of studies were included 
-The studies included patients with different types of infection 
-Different outcome measures were used: 
 In-hospital mortality 
 7-days mortality 
 30-day mortality 
-Studies used various designs: 
 prospective and retrospective observational 
studies 
-Different time points to calculate the scores was used 
Conclusion 
qSOFA score ≥ 2 and 
SIRS score ≥ 2 are 
strongly associated 
with mortality in ED 
patients with 
infections.  
qSOFA has a low 
sensitivity. 
qSOFA and SIRS 
have limitations as 
risk stratification tools 
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GRADE 
Class of Evidence (CoE)  IIb 
Recommendation B 
Objective Material and methods  Results Discussion 
To determine the 
association between 
qSOFA scores and 
outcomes in adult ED 






67475 ED adult visits meeting study 
criteria. Of whom 22.530 meet the 
inclusion/exlusion criteria and were 
admitted. 
Inclusion criteria 
Adult (>18 years)  
Patients for whom a qSOFA score 
could be calculated within 2 minutes 
or less and reporting of vital signs  
 systolic blood pressure, 
 respiratory rate 





Patients triaged to fast-track, 
dentistry, psychiatry, and labor and 
delivery were excluded 
Statistic methods: 
All analyses were performed with 
SPSS version 23.0; IBM, Armonk, 
NY.Univariate and multivariate 
analyses were performed to explore 
the association between qSOFA 
scores and inpatient mortality, 
admission, and length of stay. 
Receiver operating characteristics 
curve analysis and c statistics were 
also calculated for ICU admission 
and mortality. 
Of the 22.530 study patients, 16.507 (73%) had a qSOFA score of 
0, 5290 (23%) had a score of 1649 (3%) had a score of 2, and 84 
(0.4%) had a score of 3.  
Primary results 
The primary outcome was inhospital mortality. 
The sensitivity and specificity of a qSOFA score greater than or 
equal to 2 for predicting mortality were 29% (95% CI 25% to 
34%) and 97% (95% CI 97% to 
97%), respectively, with a negative predictive value of 99% (95% 
CI 99% to 99%).  
 
Secondary results 
Secondary outcomes were hospital admission, ICU admission and 
total hospital length of stay from ED triage to discharge from the 
hospital. 
ICU admission (0 (5.1%), 1 (10.5%), 2 (20.8%), and 3 (27.4%)), 
and hospital length of stay (0 (123 hours), 1 (163 hours), 2 (225 
hours), and 3 (237 hours)). Adjusted rates were also associated 
with qSOFA. The c statistics for mortality in patients with and 
without suspected infection were similarly high (0.75 (95% 
confidence interval 0.71 to 0.78) and 0.70 (95% confidence 
interval 0.65 to 0.74)), respectively. 
Checklist: 
- Are the groups comparable in relation to important background factors? 
Yes 
- Are the groups recruited from the same section of the population? Yes 
- Were the exposed individuals representative for a defined section of the 
population? Yes 
- Was the study prospective? No 
- Were exposure and outcome measured equal and reliable? Unknown 
- Were sufficient number of persons in the study followed up? Yes 
- Is it performed drop out analyses? No  
- Was the follow up time lengthy enough to prove positive and/or 
negative outcomes? Yes 
- Are important confounding factors in design/implementation 
considered? No 
- Was the person who evaluated the results (end points) blinded group 
identification? No  
 
Strengths: 
-Easy adaptable inclusion and exultation criteria  
-A large study population   
-The findings support the results from other studies 
 
Limitations: 
-The study was a single-center study 
-The study was unblinded 
-It was a retrospective study 
-A large number of ED patients did not have simultaneous vital 
signs and MEWS documented and were thus excluded, (selection bias) 
-No control for many potential confounders (laboratory tests, 
comorbidities) 
-Patients were selected into 2 groups based on whether intravenous 
antibiotics were given in the ED. This may have led to an over- or 
underestimation of the number of patients with suspected infection 
Conclusion 
Different qSOFA 




length and ICU 
admission. 
qSOFA is an easy tool 
that can be used in the 





Year of data 
collection 
2014-2015 
